Recent Advances in Hematology and Oncology, 2nd Edition
A special issue of Diagnostics (ISSN 2075-4418). This special issue belongs to the section "Clinical Laboratory Medicine".
Deadline for manuscript submissions: 31 December 2025 | Viewed by 566
Special Issue Editor
2. Division of Hematology and Oncology, Department of Internal Medicine, Tri-Service General Hospital, Taipei City, Taiwan
Interests: hematology; oncology; evidence-based medicine
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
This Special Issue is dedicated to showcasing recent breakthroughs in hematology and oncology, providing a comprehensive overview of cutting-edge research that contributes to our understanding of oncological and hematological malignancies.
We welcome submissions that explore emerging therapies, diagnostic techniques, and molecular insights, offering valuable perspectives for researchers, clinicians, and healthcare practitioners alike. Key themes include precision medicine, immunotherapy, genomics, and targeted therapies. Through this Special Issue, we will provide an indispensable resource, bridging knowledge gaps and fostering further advancements in the dynamic fields of hematology and oncology.
We look forward to receiving your contributions to this Special Issue, and we believe that your insights will significantly contribute to advancing our collective knowledge in these crucial fields.
Dr. Chohao Lee
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Diagnostics is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- hematological malignancies
- lymphoma
- leukemia
- multiple myeloma
- precision medicine
- immunotherapy
- genomics
- targeted therapies
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- Reprint: MDPI Books provides the opportunity to republish successful Special Issues in book format, both online and in print.
Further information on MDPI's Special Issue policies can be found here.
